Nanoparticle blocks key molecule involved in spread of breast cancer

Ongoing clinical trials have shown that a peptide known as PHSCN can slow or prevent the spread of metastatic breast cancer in over a third of patients treated with the drug. This drug works by binding to an activated receptor found on the surface of breast tumor cells but not normal cells.

Read the whole article on Physorg

More from Physorg